Fuso Pharmaceutical Industries,Ltd. (4538.T)

JPY 2388.0

(0.55%)

Revenue Summary of Fuso Pharmaceutical Industries,Ltd.

  • Fuso Pharmaceutical Industries,Ltd.'s latest annual revenue in 2023 was 55.4 Billion JPY , up 8.61% from previous year.
  • Fuso Pharmaceutical Industries,Ltd.'s latest quarterly revenue in 2024 Q1 was 14.62 Billion JPY , up 16.26% from previous quarter.
  • Fuso Pharmaceutical Industries,Ltd. reported a annual revenue of 51.01 Billion JPY in annual revenue 2022, up 2.79% from previous year.
  • Fuso Pharmaceutical Industries,Ltd. reported a annual revenue of 49.63 Billion JPY in annual revenue 2021, up 0.77% from previous year.
  • Fuso Pharmaceutical Industries,Ltd. reported a quarterly revenue of 13.91 Billion JPY for 2023 Q2, up 3.04% from previous quarter.
  • Fuso Pharmaceutical Industries,Ltd. reported a quarterly revenue of 13.5 Billion JPY for 2023 Q1, up 14.5% from previous quarter.

Annual Revenue Chart of Fuso Pharmaceutical Industries,Ltd. (2023 - 2004)

Historical Annual Revenue of Fuso Pharmaceutical Industries,Ltd. (2023 - 2004)

Year Revenue Revenue Growth
2023 55.4 Billion JPY 8.61%
2022 51.01 Billion JPY 2.79%
2021 49.63 Billion JPY 0.77%
2020 49.25 Billion JPY 5.01%
2019 46.9 Billion JPY 1.8%
2018 46.07 Billion JPY 0.38%
2017 45.9 Billion JPY -1.88%
2016 46.78 Billion JPY 2.25%
2015 45.75 Billion JPY -2.74%
2014 47.04 Billion JPY -4.19%
2013 49.1 Billion JPY 1.0%
2012 48.61 Billion JPY 9.59%
2011 44.35 Billion JPY -6.55%
2010 47.46 Billion JPY 1.95%
2009 46.56 Billion JPY 1.44%
2008 45.9 Billion JPY 4.34%
2007 43.99 Billion JPY 1.9%
2006 43.16 Billion JPY 1.16%
2005 42.67 Billion JPY 1.75%
2004 41.93 Billion JPY 0.0%

Peer Revenue Comparison of Fuso Pharmaceutical Industries,Ltd.

Name Revenue Revenue Difference
Pharma Foods International Co., Ltd. 62.14 Billion JPY 10.847%
Takeda Pharmaceutical Company Limited 4263.76 Billion JPY 98.701%
Sumitomo Pharma Co., Ltd. 314.55 Billion JPY 82.386%
Shionogi & Co., Ltd. 435.08 Billion JPY 87.265%
Wakamoto Pharmaceutical Co.,Ltd. 7.73 Billion JPY -615.985%
Nippon Shinyaku Co., Ltd. 148.25 Billion JPY 62.628%
Kaken Pharmaceutical Co., Ltd. 72.04 Billion JPY 23.094%
Eisai Co., Ltd. 741.75 Billion JPY 92.53%
Morishita Jintan Co., Ltd. 12.4 Billion JPY -346.606%
Hisamitsu Pharmaceutical Co., Inc. 141.7 Billion JPY 60.901%
Mochida Pharmaceutical Co., Ltd. 102.88 Billion JPY 46.148%
Nippon Chemiphar Co., Ltd. 30.74 Billion JPY -80.194%
Tsumura & Co. 150.84 Billion JPY 63.27%
Kissei Pharmaceutical Co., Ltd. 75.57 Billion JPY 26.691%
Torii Pharmaceutical Co., Ltd. 54.63 Billion JPY -1.406%
Towa Pharmaceutical Co., Ltd. 227.93 Billion JPY 75.692%
Fuji Pharma Co., Ltd. 40.88 Billion JPY -35.503%
Zeria Pharmaceutical Co., Ltd. 75.72 Billion JPY 26.833%
KYORIN Holdings, Inc. 119.53 Billion JPY 53.648%
Taiko Pharmaceutical Co.,Ltd. 5.04 Billion JPY -999.325%
Daito Pharmaceutical Co.,Ltd. 46.89 Billion JPY -18.149%
SymBio Pharmaceuticals Limited 5.58 Billion JPY -891.215%
MedRx Co., Ltd 26 Million JPY -213000.0%
Mizuho Medy Co.,Ltd. 10.98 Billion JPY -404.161%
Solasia Pharma K.K. 617 Million JPY -8879.903%
Modalis Therapeutics Corporation - JPY -Infinity%
ASKA Pharmaceutical Holdings Co.,Ltd. 62.84 Billion JPY 11.834%
Sawai Group Holdings Co., Ltd. 176.86 Billion JPY 68.673%
Cyfuse Biomedical K.K. 61.11 Million JPY -90563.045%
Toho Holdings Co., Ltd. 1476.71 Billion JPY 96.248%
Koa Shoji Holdings Co.,Ltd. 22.13 Billion JPY -150.319%